While reporting financial results for the fourth quarter on Monday, pet healthcare provider IDEXX Laboratories, Inc. (IDXX) initiated its earnings and revenue guidance for the full-year 2026, in line with analysts' estimates.
For fiscal 2026, the company now projects earnings in a range of $14.29 to $14.80 per share on revenues between $4.632 billion and $4.720 billion, with revenue growth of 7.6 to 9.6 percent and organic revenue growth of 7 to 9 percent.
On average, analysts polled expect the company to report earnings of $14.45 per share on revenues of $4.66 billion for the year. Analysts' estimates typically exclude special items. In Monday's pre-market trading, IDXX is trading on the Nasdaq at $669.95, down $0.51 or 0.08 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.